Aurobindo Pharma up on US approval

The stock ended at Rs 895, up 1% from its previous close. The counter clocked volumes of 50,371 shares  as compared to the two-week daily average traded volumes of 31,409 shares on the BSE.
_____________________________________

(Updated at 1044hrs)

Aurobindo Pharma gains on getting US nod.

The stock opened at Rs 892 and soared to a high of Rs 904. The stock is now trading at Rs 899, up 1.5% from its previous close. The counter has clocked volumes of 11,810 shares as compared to the two-week daily average traded volumes of 31,410 shares on the BSE.

The company has receieved the approval from the US drug regulator for its anti-allergic syrup (Centrizine Hydrochloride syrup).